Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice, A Taylor… - Supportive Care in …, 2010 - Springer
Purpose Aprepitant was shown previously to be effective for prevention of chemotherapy-
induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in …
被引用次数：293 相关文章

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice… - Supportive care in …, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose Aprepitant was shown previously to be effective for prevention of chemotherapy-
induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in …

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice… - Supportive Care in …, 2010 - search.proquest.com
Aprepitant was shown previously to be effective for prevention of chemotherapy-induced
nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in breast …

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice… - Supportive Care in …, 2010 - search.ebscohost.com
Purpose Aprepitant was shown previously to be effective for prevention of chemotherapy-
induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in …

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice, A Taylor… - Supportive Care in …, 2010 - go.gale.com
Purpose Aprepitant was shown previously to be effective for prevention of chemotherapy-
induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in …

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice, A Taylor… - Supportive Care in …, 2009 - europepmc.org
Purpose Aprepitant was shown previously to be effective for prevention of chemotherapy-
induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in …

[引用][C] Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and …

R BL - Support Care Cancer, 2009 - cir.nii.ac.jp
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a
broad range of moderately emetogenic chemotherapies and tumor types : a randomized …

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor …

BL Rapoport, K Jordan, JA Boice, A Taylor… - Supportive Care in …, 2010 - infona.pl
Purpose Aprepitant was shown previously to be effective for prevention of chemotherapy-
induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy (MEC) in …

[引用][C] Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and …

BL Rapoport, K Jordan, JA Boice, A Taylor… - Supportive Care in …, 2009 - cir.nii.ac.jp
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a
broad range of moderately emetogenic chemotherapies and tumor types: a randomized …

[引用][C] Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and …

BL Rapoport, K Jordan, JA Boice, A Taylor… - Supportive Care in …, 2010 - Springer